Patients' awareness, utilization, and satisfaction with treatment modalities for the management of their osteoarthritis
Patients' awareness, utilization, and satisfaction with treatment modalities for the management of their osteoarthritis
复制标题
DOI：
10.1007/s10067-005-1102-0
复制
发表时间：
2005-09-01
影响因子：
3.4
通讯作者：
Davis, P
中科院分区：
文献类型：
--
作者：
Juby, AG;Skeith, K;Davis, P
本研究的目的是评估知识，意识，利用和满意度。骨关节炎（OA）不同治疗方式的患者。诊断为膝关节或髋关节骨性关节炎且在过去2年内参加过风湿病转诊诊所的患者符合条件。一份长达六页的自填问卷被邮寄给他们。答案是匿名的。共收回106份完整的问卷。受访者的平均年龄为64岁，其中包括71名女性。94%的受访者接受过至少8年的正规教育，75%的人患有OA至少5年。75%成功定义OA。大多数人听说过大多数治疗方法。71%的人尝试过环氧合酶-2抑制剂（COXIBs），79%的人尝试过镇痛药，56%的人尝试过物理治疗。26%的人接受过OA手术。在那些尝试过各种治疗方案的患者中，最满意的是手术、泳池疗法、助行器和麻醉性镇痛药。55%的人发现传统的非甾体抗炎药（NSAID）有帮助，65%的人从COXIB中受益。据报告，提供最多功能改善的治疗是手术，其次是类固醇注射、COMB治疗和传统NSA-ID。提供最多症状改善的治疗方式是手术，其次是COXIB和类固醇注射。当比较治疗方案时，在考虑总体满意度、功能改善和症状缓解时，其排序不同。这项研究的参与者充分了解他们的疾病及其治疗的性质。已经尝试了多种疗法，其中大多数耐受性良好。根据患者的感觉，接受手术治疗的患者在症状和功能方面的改善最好。对于那些使用抗炎药（NSAID或COXIB）的患者，改善率> 50%，尽管这低于物理治疗和镇痛药。基于该患者队列，评价较高的治疗（如手术）不一定是最广泛使用的治疗。相反，那些最广泛使用的疗法（如镇痛剂）不一定是那些提供最大感知益处的疗法。我们的结论是，在持续缺乏特定的疾病缓解治疗OA，多种治疗方案需要探索，以解决个别患者的功能和症状的需要。
The objective of this study was to evaluate the knowledge, awareness, utilization, and satisfaction. of patients with different treatment modalities for osteoarthritis (OA). Patients with a diagnosis of OA of the knee or hip who had attended a rheumatology referral clinic over the preceding 2 years were eligible. A six-page self-administered questionnaire was mailed to them. Responses were anonymous. One hundred and six completed questionnaires were returned. The average age of the respondents was 64 years and included 71 females. Ninety-four percent of respondents had at least 8 years of formal education, and 75% had had OA for at least 5 years. Seventy-five percent successfully defined OA. The majority had heard of most treatment modalities. Seventy-one percent had tried cyclooxygenase-2 inhibitors (COXIBs), 79% analgesics, and 56% physiotherapy. Twenty-six percent had had surgery for their OA. Of those that had tried the various treatment options, the most satisfaction occurred with surgery, pool therapy, walking aids, and narcotic analgesics. Fifty-five percent found traditional nonsteroidal anti-inflammatory drugs (NSAIDs) helpful and 65% benefited from the COXIBs. Treatment reported as providing the most improvement in function was surgery, followed by steroid injections, COMB therapy, and traditional NSA-IDs. Treatment modalities providing the most symptomatic improvement were surgery, followed by COXIBs and steroid injections. When treatment options were compared, their rank ordering differed when considering overall satisfaction, functional improvement, and symptomatic relief. The participants in this study were well informed as to the nature of their disease and its treatment. A wide number of therapies had been tried, most of which were well tolerated. According to patient perception, those undergoing surgical treatment had the best improvement in symptoms and function. For those using anti-inflammatories (NSAIDs or COXIBs) improvement occurred in > 50%, though this was less than for physiotherapy and analgesics. Based on this cohort of patients, treatments that were rated highly (such as surgery) were not necessarily those that were the most widely experienced. Conversely, those therapies that were the most widely accessed (such as analgesics) were not necessarily those that provided the maximum perceived benefit. We conclude that in the continued absence of specific disease-modifying therapies for OA, multiple therapeutic options need to be explored to address individual patient's functional and symptomatic needs.